Key result
Calcitriol lowers systolic blood pressure by ~20 mmHg vs placebo in older hypertensive adults.
RCT (n=36)
Double-blind
Randomized
Answers are grounded in this paper and cite their sources.
Recent studies suggest that vitamin D plays an important role in the control of blood pressure. Unfortunately, because older adults are more likely to have low 25-hydroxyvitamin-D [25(OH)D] levels, this study investigated whether calcitriol supplementation reduces blood pressure in older adults with hypertension. The design was a double-blind placebo-controlled randomized clinical trial with 36 randomly assigned subjects (71.7 ± 10 years). Blood pressure and serum levels of 25(OH)D before and after calcitriol intervention (1,000 IU daily for 6 weeks; n = 22) or placebo (n = 23) for 6 weeks were analyzed. At the end of the study, the calcitriol group presented a significant decrease of systolic blood pressure [20.25 mmHg (p = 0.001)] and diastolic blood pressure [7 mmHg (p = 0.01)], compared with the placebo group. In conclusion, 1,000 IU/day of calcitriol for 6 weeks efficiently reduced systolic and diastolic blood pressure levels in this population of older adults presenting with high blood pressure (Clinical Trial Approbation NCT02047799).
No takes yet. Share an insight, caveat, or question.
Bricio‐Barrios et al. (2016) conducted an RCT in Hypertension (n=36). Calcitriol vs. Placebo was evaluated on Systolic and diastolic blood pressure (MD -20.25 mmHg (SBP), -7 mmHg (DBP), p=0.001 (SBP), 0.01 (DBP)). Calcitriol (1,000 IU/day for 6 weeks) reduced systolic and diastolic blood pressure vs placebo in older adults with hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: